06.22.12
PharmaNet/i3, inVentiv Health’s clinical segment, has released the PharmaNet/i3 Interactive Response Technologies (IRT) clinical trial randomization and supply management system that provides configurable functionality for both the web (IWR) and phone (IVR). Offered via a “Software as a Service” (SaaS) delivery model, the new release is designed provide comprehensive randomization and supply management solutions for trials using configurable, pre-validated software components that deploy solutions over the web and phone.
The company’s IRT project managers partner with clients and study teams to identify requirements for each study, and coordinate the team to help produce solutions. IRT project managers remain the central contact for support throughout the study lifecycle along with 24/7 support.
“PharmaNet/i3 has been providing IRT solutions for nearly a decade and has delivered every study on-time without exception. Being part of a full service CRO, we understand the challenges study managers face during study startup. Knowing that they can count on a quality IRT system to be delivered within their timeline enables the manager and study team to focus their attention on the many other key start-up activities,” said Charles Gasman, executive director of Interactive Technologies, PharmaNet/i3.
The company’s IRT project managers partner with clients and study teams to identify requirements for each study, and coordinate the team to help produce solutions. IRT project managers remain the central contact for support throughout the study lifecycle along with 24/7 support.
“PharmaNet/i3 has been providing IRT solutions for nearly a decade and has delivered every study on-time without exception. Being part of a full service CRO, we understand the challenges study managers face during study startup. Knowing that they can count on a quality IRT system to be delivered within their timeline enables the manager and study team to focus their attention on the many other key start-up activities,” said Charles Gasman, executive director of Interactive Technologies, PharmaNet/i3.